![]() ![]() There's also increasing buy-in from healthcare stakeholders, including payers and providers, around integrating digital therapeutics and building payment models around them.ĭigital therapeutics were a huge highlight in 2021, but "when we think about the space, I think we're still in the early innings here," said Amanda DiTrolio, a healthcare intelligence analyst at CB Insights. Startups are growing their body of clinical evidence to back up their technologies. ![]() Coverage pathways for prescription digital therapeutics widened last year, allowing regulatory approvals to escalate. Digital therapeutics allows care delivery to disconnect, in a way, from the supply side, enabling patients to receive care asynchronously and remotely, without doctors having to constantly monitor the apps.Ī number of factors are converging to spur investments in digital therapeutics. The goal of digital therapeutics is to treat chronic conditions at scale, alleviating some of the biggest stressors on the medical system right now, such as physician shortages, Albanese said. digital therapeutics companies have increased an average of 40% a year over the past seven years, according to McKinsey. It's a continuing trend: Investments in U.S. "It's hard to see what could stop it," said Marc Albanese, senior director of research for healthcare and emerging tech at market intelligence firm CB Insights.ĭigital therapeutics and personalized medicineĭigital therapeutics saw significant funding growth in 2021, with startups delivering medical interventions using evidence-based software to manage and treat a broad spectrum of diseases reporting surging investments. Market watchers see digital therapeutics, personalized medicine, provider-focused infrastructure and mental health and chronic condition management as particularly ripe for continued investment as the pandemic moves into its third year. "I expect this positive momentum in deal flow to continue in 2022," said Ravi Kumar, a partner at professional services firm the Connor Group. Investors and market watchers are wary on making firm forecasts that 2022 will break 2021's record, but most are eyeing the year through rose-colored glasses. U.S.-based digital health startups brought in almost $30 billion in 2021, almost doubling the total investment the year prior. Health tech grabbed a serious share of the attention. ![]() The industry raised the second-highest amount of global venture funding in 2021, trailing financial services, according to Crunchbase data. That money has got to go somewhere, and it's a good bet the healthcare sector will be a major recipient. venture capital firms raised almost $13 billion, according to PitchBook data - about equal to what the firms raised in an entire year about a decade ago. That's ameliorating concerns that demand for such solutions would plummet once the brunt of COVID-19 subsides.ĭigital health startups capitalizing on the need to manage costly, pervasive conditions, free up physicians and enable care at scale, along with the shift to individualized, high-touch medicine, are expected to bring in the lion's share of funding this year, experts say.īarely a week into 2022, U.S. In addition, the adoption of digital health products and services seems to be stabilizing, with sustained patient demand and no widespread rollbacks in virtual services from providers. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |